GlassScriptPhysician profile
Ravi Jayanti
NPI 1457598088
$14,206.32
in general payments reported to CMS, 2019-2025
28 companies · $6,192 in 2025
The $6,192 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.88 · 2020: $213 · 2021: $402 · 2022: $838 · 2023: $4,579 · 2024: $1,922 · 2025: $6,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,458 · Travel and Lodging: $4,568 · Grant: $2,667 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,458.05 |
| Travel and Lodging | $4,567.80 |
| Grant | $2,666.66 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,251.77 | 2022-2025 | Corevalve Evolut R, Onyx Frontier, Telescope |
| Edwards Lifesciences Corporation | $2,855.86 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $2,046.22 | 2021-2025 | Watchman Flx, General - Therapies, Avvigo Guidance System |
| Abiomed | $1,194.81 | 2023-2025 | Impella |
| W. L. Gore & Associates, INC. | $547.15 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Amgen INC. | $298.56 | 2021-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $263.91 | 2020-2023 | Brilinta |
| Terumo Medical Corporation | $259.25 | 2024 | |
| Cook Medical LLC | $232.66 | 2023-2025 | Zilver Ptx, Zenith Alpha |
| Janssen Pharmaceuticals, INC | $209.26 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.71 | 2020-2025 | Lifevest |
| Shockwave Medical, INC | $158.78 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Incorporated | $140.85 | 2020 | |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $60.55 | 2022-2023 | Camzyos |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Becton, Dickinson and Company | $46.47 | 2022 | |
| Alkermes, INC. | $36.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.14 | 2025 | |
| Biosense Webster, INC. | $29.21 | 2021 | |
| Canon Medical Systems USA, INC. | $23.63 | 2024 | Interventional Angiography System |
| Kiniksa Pharmaceuticals, LTD. | $18.67 | 2023 | Arcalyst |
| Biotronik INC. | $18.49 | 2021 | |
| Pfizer INC. | $15.67 | 2023 | |
| Nxstage Medical, INC. | $14.63 | 2022 | |
| Esperion Therapeutics, INC. | $14.58 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Jayanti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.